SCHEMBL370701

SCHEMBL370701

[c]1ccccc1-c1cn2ccccc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 16/20 0.51
NPC1 O15118 15/20 0.51
KDM4E B2RXH2 11/20 0.51
POLB P06746 2/20 0.51
SMN1; SMN2 Q16637 8/20 0.50
GFER P55789 3/20 0.50
NFKB1 P19838 2/20 0.50
NFKB2 Q00653 2/20 0.50
RELA Q04206 2/20 0.50
ALOX12 P18054 1/20 0.50
PKM P14618 7/20 0.48
EPHX2 P34913 1/20 0.48
MEN1 O00255 1/20 0.48
GAA P10253 1/20 0.48
MIF P14174 1/20 0.48
KMT2A Q03164 1/20 0.48
ALDH1A1 P00352 9/20 0.46
MAPT P10636 4/20 0.46
HPGD P15428 3/20 0.46
HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31731985 0.80 RAB9A (0.67) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL8010437 0.76 ALDH1A1 (0.60) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL713889 0.75 RAB9A (0.66) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL13325909 0.74 RAB9A (0.83) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL13131131 0.73 RAB9A (0.69) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL13325938 0.73 RAB9A (0.80) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL29080554 0.73 RAB9A (0.74) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL966793 0.73 RAB9A (0.74) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL31154574 0.73 RAB9A (0.74) RAB9ANPC1KDM4EPOLBSMN1; SMN2
SCHEMBL722446 0.72 CHEK1 (0.43) RAB9ANPC1KDM4ESMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771843-B2 Fluorene derivative, organic compound, and light-emitting element, light-emitting device, and electronic device using the compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-07-08 US disclosed
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-01 US disclosed
WO-2012007086-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120049768-A1 Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound AFF2, MAPRE2, AFF4 RAB9A 440/4885NPC1 2154/4885KDM4E 2863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.